Oxford BioMedica PLC (OXB) — Cash Flow Reinvestment Rate
Oxford BioMedica PLC (OXB) has a Cash Flow Reinvestment Rate of 0.64x as of June 2025, reinvesting GBX1.51 Million (capex GBX1.51 Million ) from operating cash flow of GBX2.35 Million. See OXB free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oxford BioMedica PLC Cash Flow Reinvestment Rate (2007–2021)
Historical reinvestment intensity for Oxford BioMedica PLC across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Oxford BioMedica PLC.
Annual Cash Flow Reinvestment Rate for Oxford BioMedica PLC (2007–2021)
Year-by-year capital reinvestment analysis for Oxford BioMedica PLC. See Oxford BioMedica PLC (OXB) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.74x | GBX18.92 Million | GBX25.45 Million | GBX9.46 Million | ▼ -85.4% |
| 2020 | 5.10x | GBX15.88 Million | GBX3.12 Million | GBX13.36 Million | ▲ +299.5% |
| 2018 | 1.28x | GBX16.42 Million | GBX12.87 Million | GBX10.15 Million | ▼ -53.9% |
| 2017 | 2.77x | GBX8.24 Million | GBX2.98 Million | GBX1.97 Million | ▲ +2122.2% |
| 2009 | 0.12x | GBX288.00K | GBX2.31 Million | GBX288.00K | ▲ +39.8% |
| 2007 | 0.09x | GBX421.00K | GBX4.73 Million | GBX421.00K | — |